Research & Development
CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases
The agreement with Beth Israel Deaconess Medical Center aims to solidify important technology for CND’s Syn-One Test, a skin-based test that aids the diagnosis of synucleinopathies, a family of neurodegenerative disorders.
March 22, 2023
Fluorescent RNA enables real time detection of neurodegenerative disease driver in live cells
Researchers have found an RNA structure associated with a neurodegenerative disease in live cells using a technique based on fluorescence-microscopic spectroscopy.
February 7, 2023
State of Arizona awards CND Life Sciences $4.2 million to develop neurodegenerative biosignatures library
With the funds from the Governor's Office, CND plans to develop and open the Digital Biosignatures Lab in 2023 adjacent to its headquarters, adding AI-driven image analysis and other digital tools to the company’s cutaneous neurodiagnostic technology.
December 28, 2022
Labcorp NfL test confirms neurodegenerative disease
The neurofilament light chain (NfL) blood test will allow doctors to identify and verify signs of neurodegenerative disease, enabling physicians to provide a more effective and efficient path to diagnosis and treatment for patients, the firm said.
July 12, 2022
NIH test inspects abnormal tau in cerebrospinal fluid
Abnormalities in the protein tau are at the root of more than 25 neurodegenerative conditions, including Alzheimer's disease, and better means of testing are needed, other than the analysis of postmortem brain tissue, the researchers noted.
October 16, 2019
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
Simple blood test can detect PTSD biomarkers
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Illumina NGS software to enable tertiary analysis for oncology, rare disease
Serum protein in study predicted which patients might die without a liver transplant
AmoyDx PLC Panel gets Japanese approval as companion diagnostic for NSCLC
Page 1 of 1